KRAS and sarcoma: A recent comprehensive molecular study on DICER1-associated sarcomas identified recurrent alterations in TP53 (32/80, 40%), KRAS (17/80, 21%), NRAS (6/80, 8%), and NF1 (8/80, 10%)6.